TY - JOUR
T1 - Regulation of APC/C Cdc20 activity by RASSF1A-APC/C Cdc20 circuitry
AU - Chow, C.
AU - Wong, N.
AU - Pagano, M.
AU - Lun, S. W.M.
AU - Nakayama, K. I.
AU - Nakayama, K.
AU - Lo, K. W.
N1 - Funding Information:
This work was supported by Michael and Betty Kadoorie Cancer Genetics Research Program II (MBKCGRPII), Li Ka Shing Institute of Health Science and Hong Kong Research Grant Council (440606).
PY - 2012/4/12
Y1 - 2012/4/12
N2 - RASSF1A is a key tumor-suppressor gene that is often inactivated in a wide variety of solid tumors. Studies have illustrated that RASSF1A plays vital roles in the regulation of cell-cycle progression and functions as a guardian of mitosis. Nevertheless, the precise mechanism of RASSF1A-dependent regulation of mitosis remains largely unclear. APC/C Cdc20 is the master switch and regulator of mitosis. The activity of APC/C Cdc20 is tightly controlled by phosphorylation and specific inhibitors to ensure the sequential ubiquitination of downstream targets. Here, we report on the novel finding of a regulated circuitry that controls the timely expression and hence activity of APC/C Cdc20 during mitosis. Our study showed that RASSF1A and APC/C Cdc20 form a molecular relay that regulates the APC/C Cdc20 activity at early mitosis. We found that RASSF1A inhibits APC/C Cdc20 function through its D-box motifs. Paradoxically, RASSF1A was also demonstrated to be ubiquitinated by APC/C Cdc20 in vitro and degraded at prometaphase despite of active spindle checkpoint presence. The first two unique D-boxes at the N-terminal of RASSF1A served as specific degron recognized by APC/C Cdc20. Importantly, we found that Aurora A and Aurora B directly phosphorylate RASSF1A, a critical step by which RASSF1A switches from being an inhibitor to a substrate of APC/C Cdc20 during the course of mitotic progression. As a result of RASSF1A degradation, APC/C Cdc20 can then partially activate the ubiquitination of Cyclin A in the presence of spindle checkpoint. This circuitry is essential for the timely degradation of Cyclin A. To conclude, our results propose a new model for RASSF1A-APC/C Cdc20 interaction in ensuring the sequential progression of mitosis.
AB - RASSF1A is a key tumor-suppressor gene that is often inactivated in a wide variety of solid tumors. Studies have illustrated that RASSF1A plays vital roles in the regulation of cell-cycle progression and functions as a guardian of mitosis. Nevertheless, the precise mechanism of RASSF1A-dependent regulation of mitosis remains largely unclear. APC/C Cdc20 is the master switch and regulator of mitosis. The activity of APC/C Cdc20 is tightly controlled by phosphorylation and specific inhibitors to ensure the sequential ubiquitination of downstream targets. Here, we report on the novel finding of a regulated circuitry that controls the timely expression and hence activity of APC/C Cdc20 during mitosis. Our study showed that RASSF1A and APC/C Cdc20 form a molecular relay that regulates the APC/C Cdc20 activity at early mitosis. We found that RASSF1A inhibits APC/C Cdc20 function through its D-box motifs. Paradoxically, RASSF1A was also demonstrated to be ubiquitinated by APC/C Cdc20 in vitro and degraded at prometaphase despite of active spindle checkpoint presence. The first two unique D-boxes at the N-terminal of RASSF1A served as specific degron recognized by APC/C Cdc20. Importantly, we found that Aurora A and Aurora B directly phosphorylate RASSF1A, a critical step by which RASSF1A switches from being an inhibitor to a substrate of APC/C Cdc20 during the course of mitotic progression. As a result of RASSF1A degradation, APC/C Cdc20 can then partially activate the ubiquitination of Cyclin A in the presence of spindle checkpoint. This circuitry is essential for the timely degradation of Cyclin A. To conclude, our results propose a new model for RASSF1A-APC/C Cdc20 interaction in ensuring the sequential progression of mitosis.
UR - http://www.scopus.com/inward/record.url?scp=84859750018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859750018&partnerID=8YFLogxK
U2 - 10.1038/onc.2011.372
DO - 10.1038/onc.2011.372
M3 - Article
C2 - 21874044
AN - SCOPUS:84859750018
SN - 0950-9232
VL - 31
SP - 1975
EP - 1987
JO - Oncogene
JF - Oncogene
IS - 15
ER -